ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Eukaryotic Gene Expression
インパクトファクター: 2.156 5年インパクトファクター: 2.255 SJR: 0.649 SNIP: 0.599 CiteScore™: 3

ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502

Critical Reviews™ in Eukaryotic Gene Expression

DOI: 10.1615/CritRevEukarGeneExpr.v5.i2.20
pages 127-156

Cyclins, Cyclin-Dependent Kinases and Cdk Inhibitors: Implications in Cell Cycle Control and Cancer

Timothy K. MacLachlan
Jefferson Cancer Institute, Departments of Microbiology/Immunology and Pathology, Thomas Jefferson University, Philadelphia, PA 19107
Nianli Sang
Department of Biology, College of Arts and Sciences, Drexel University; Department of Pathology and Laboratory Medicine, Drexel University College of Medicine, Philadelphia, Pennsylvania
Antonio Giordano
Department of Pathology, Anatomy and Cell Biology, Jefferson Medical College, Philadelphia, PA 19107

要約

A significant portion of cellular scientific literature published is dedicated to describing the cloning, the link to cancer, or the characterization of proteins involved in the progression of the cell cycle. With this abundance of information, the cascading pathways of molecular events that occur in the cell cycle are proving to be exceedingly complicated. Originally, the sole regulator of the fission yeast cell division cycle, cdc2, was thought to also regulate mammalian cell cycles in the same manner. However, mammalian cdc2 has now been joined by seven well-characterized relatives acting at distinct points in the cell cycle. These kinases are activated by larger proteins called cyclins, named with respect to their cyclical expression and degradation. Therefore, the catalytic subunits of these complexes are named cyclin-dependent kinases (cdks). In the event that the cell must stop normal cycling behavior, a number of cdk inhibitors, which have only begun to be characterized, function in inhibiting the kinase ability of cdks, among other nonproliferative acts. The external environment manipulates cellular proliferation and differentiation by stimulating or inhibiting certain signal transduction pathways. However, each component of the cell cycle machinery, as they are the final executors in cell division, has the potential to elicit or to contribute to a neoplastic phenotype. This review focuses on the characterization of each member of the cell cycle protein family and also addresses the potential role each plays in cancer.


Articles with similar content:

MARs of Antigen Receptor and Co-Receptor Genes
Critical Reviews™ in Eukaryotic Gene Expression, Vol.9, 1999, issue 3-4
Richard H. Scheuermann , William T. Garrard
Retrodifferentiation and Cell Death
Critical Reviews™ in Oncogenesis, Vol.5, 1994, issue 4
Ralf Hass
Androgen Receptor: An Overview
Critical Reviews™ in Eukaryotic Gene Expression, Vol.5, 1995, issue 2
Alan Saltzman, Chihuei Wang, Han-Jung Lee, Shuyuan Yeh, Winjing Young, Chawnshang Chang, Atsushi Mizokami, Evan T. Keller
Role of Epstein-Barr Virus and Human Papillomavirus Coinfection in Oral and Anogenital Carcinogenesis: Potential Tumorigenic Pathways
Critical Reviews™ in Oncogenesis, Vol.24, 2019, issue 4
Cláudio Gleidiston Lima da Silva, Marcos Antonio Pereira de Lima, Ilara Parente Pinheiro Teodoro, Marcos Venício Alves Lima
The Goldilocks Conundrum: NLR Inflammasome Modulation of Gastrointestinal Inflammation during Inflammatory Bowel Disease
Critical Reviews™ in Immunology, Vol.36, 2016, issue 4
Veronica M. Ringel-Scaia, Irving C. Allen, Dylan K. McDaniel